GCIA
TECH icon

Gabelli & Co Investment Advisers’s Bio-Techne TECH Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.4M Buy
+161,250
New +$8.71M 1.66% 15

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Gabelli & Co Investment Advisers's TECH Position: Q2 2026 in Review

Gabelli & Co Investment Advisers opened a new position in Bio-Techne (TECH) in Q2 2026: 161,250 shares worth $11.4M. The stake represents 1.66% of the portfolio and ranks #15 among its holdings.

594 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Gabelli & Co Investment Advisers held 161,250 shares of Bio-Techne worth $11.4M as of Q2 2026.
  • Bio-Techne was a new Gabelli & Co Investment Advisers position in Q2 2026.
  • Bio-Techne made up 1.66% of Gabelli & Co Investment Advisers's portfolio in Q2 2026, its #15 holding.
  • 594 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.